Clinical Trial Update: Intranasal Oxytocin and Learning in Autism [Phase 2]

View source ↗

Summary

Phase 2 trial investigating intranasal oxytocin and learning in autism completed; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Oxytocin (Oxytocin)

Snippet

Sponsor: Robert Schultz | Conditions: Autism Spectrum Disorders | Phase 2 | Status: COMPLETED | Results posted: 2017-03-30